| 12410133 |
Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof |
Lianfeng Huang, Nancy Tsou, Jun Xu, Qun Zhang |
2025-09-09 |
| 11680046 |
Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof |
Lianfeng Huang, Nancy Tsou, Jun Xu, Qun Zhang |
2023-06-20 |
| 11273159 |
Pharmaceutical formulations |
Cheryl A. Grice, Joel P. Zingerman, Hibreniguss Terefe, Isaac Ghebre-Sellassie |
2022-03-15 |
| 11053199 |
Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof |
Lianfeng Huang, Nancy Tsou, Jun Xu, Qun Zhang |
2021-07-06 |
| 9981930 |
MAGL inhibitors |
Cheryl A. Grice, Donald L. Hertzog, Daniel J. Buzard |
2018-05-29 |
| 9676804 |
Methods for preparing anti-viral nucleotide analogs |
Denise A. Colby, Andrew Anthony Martins, Benjamin James Roberts, Robert Scott |
2017-06-13 |
| 9346841 |
Methods for preparing anti-viral nucleotide analogs |
Denise A. Colby, Andrew Anthony Martins, Benjamin James Roberts, Robert Scott |
2016-05-24 |
| 9029534 |
Methods for preparing anti-viral nucleotide analogs |
Denise A. Colby, Andrew Anthony Martins, Benjamin James Roberts, Robert Scott |
2015-05-12 |
| 8664386 |
Methods for preparing anti-viral nucleotide analogs |
Denise A. Colby, Andrew Anthony Martins, Benjamin James Roberts, Robert Scott |
2014-03-04 |